Labor Market Pulse ArchiveSubscribe to a report

Labor Market Pulse · Life Sciences · September 2026

Life Sciences Labor Market Report: Oxnard-Thousand Oaks-Ventura, CA MSA — September 2026

Oxnard regulatory pay slips as scientist premiums keep climbing.

Regulatory Affairs Specialist pay fell to $104,497 in the Oxnard metro even as Research Scientist pay climbed to $204,335 — a 56% premium over the national median that signals deepening talent scarcity.

Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.

Key indicators

  • Ventura County unemployment: 5.0% — vs 4.1% national, August 2026
  • Research Scientist pay premium: +56% — Metro $204,335 vs national $131,354
  • California labor force change: -351,100 — 12 months ending August 2026
  • CA life sciences employment: 406,000+ — avg salary $192,179 statewide

Key takeaways

Regulatory Affairs pay is falling locally while scarcity rises nationally.

Metro median advertised pay for Regulatory Affairs Specialist dropped significantly even as national reporting flags VP-level regulatory talent commanding $320K–$580K amid acute global shortage. The divergence may suggest Oxnard-area postings skew toward compliance-tier roles being absorbed or restructured, while the real competitive pressure sits one or two levels up the ladder.

Research Scientist pay gap over national median keeps widening.

Metro median of $204,335 against a $131,354 national figure is a nearly 56% premium, up significantly this month. That spread reflects both genuine scarcity in a shrinking labor pool and the premium employers must pay to retain R&D talent that could otherwise relocate to denser biotech hubs.

Clinical Data Manager demand is accelerating against a national decline.

Metro pay rose significantly to $149,065 while the national median fell moderately to $123,031 — an unusual local-national divergence. Consider whether this reflects clinical trial activity concentrating regionally, making data management a function worth insourcing rather than routing through a CRO.

Manufacturing consolidation elsewhere may ease local hiring pressure.

BioMarin's planned Novato consolidation and Amgen's July layoffs signal statewide manufacturing footprint contraction, potentially releasing experienced CMC and quality talent into the broader California market. Ventura County employers weighing build-vs-outsource manufacturing decisions should watch whether this talent surfaces locally over the next quarter.

Median advertised pay by role — Oxnard-Thousand Oaks-Ventura, CA MSA

Life Sciences roles, September 2026. Source: WageScape.
Role25th percentileMedian advertised pay75th percentileMetro trendNational median
Research Scientist$112,195$204,335$215,630Significant increase$131,354
Clinical Research Associate$66,928$102,557$122,914Significant increase$90,956
Lab Technician$45,781$66,468$66,468Stable$47,402
Regulatory Affairs Specialist$81,271$104,497$111,116Significant decline$104,000
Clinical Data Manager$97,746$149,065$151,280Significant increase$123,031
Biostatistician$192,151$192,608$192,745Significant increase$133,322
Validation Engineer$90,741$112,703$126,763Moderate increase$108,377

WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON

Local market conditions

Ventura County's unemployment rate sits at 5.0% in August 2026, a point above the national rate and consistent with California's broader labor market softness, yet unfilled openings remain elevated — a mismatch pointing to skills and credential gaps rather than weak demand. Net out-migration and a shrinking civilian labor force continue to constrain the metro's candidate pool, forcing employers competing for specialized scientific and regulatory talent to pull from a shallower local bench than headline unemployment would suggest.

What it means

Advertised pay for Research Scientist ($204,335 metro median) and Clinical Data Manager ($149,065) has risen significantly even as Regulatory Affairs Specialist pay fell locally — a divergence consistent with national reporting that regulatory talent is being pulled into strategic, senior-level roles while mid-level specialist postings soften amid consolidation pressure. With Ventura County's labor force contracting and life science manufacturing concentrated in a state where BioMarin and Amgen are both trimming headcount, leaders face a genuine build-vs-outsource inflection point for CMC and quality functions rather than a straightforward hiring push. Organizations should evaluate whether open regulatory and manufacturing requisitions reflect true local scarcity or whether remote/hybrid sourcing and CDMO partnerships can close the gap more economically than competing on local pay alone.

Looking ahead

Worth watching: Ventura Coastal's WARN filing for 71 roles effective September 18 adds to a thin but real local layoff signal. Watch whether displaced workers carry transferable quality or operations skills into life sciences manufacturing applicant pools.

Emerging pressure point: California's labor force contraction (351,100 fewer workers over 12 months) compounds Ventura County's own net out-migration trend. Expect continued difficulty filling specialized clinical and regulatory roles locally without expanding remote or relocation-supported sourcing.

Potential inflection point: California's $23.9 million LA County life sciences workforce investment, aimed at 10,000 jobs by 2030, could draw talent and training infrastructure toward LA/Orange County rather than Ventura. Monitor whether this shifts competitive pay pressure northward into the Oxnard metro over coming months.

Expected: With 64% of surveyed biopharma organizations still actively recruiting despite September layoffs nationally, expect continued tension between consolidation headlines and execution-critical hiring. Local employers should anticipate competing for the same scarce regulatory and CMC talent pools regardless of sector-wide headcount reductions.

Methodology

Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.

Free to read and cite with attribution to WageScape. Terms of use.